The Next Drugs:
An Atlantic Policy Update on Biosimilars

June 7, 2017
Washington, DC

Biosimilars – and the policy and regulatory debates surrounding these complex large-molecule drugs – continue to be a hot topic in Washington.  A patent case in front of the Supreme Court and laws making their way through Congress have the potential to change the market and industry.

The Atlantic convened key stakeholders to discuss the state of and future for biosimilars. What impact will ongoing regulatory and policy considerations have? What can stakeholders expect when it comes to patents and exclusivity? And what effect will the priorities of leadership in Congress and the Administration have on the industry across the next few years?



Watch full session videos

Presented by

Atlantic Live

Speakers

Agenda

  • Wednesday, June 07
  • 8:20 a.m.WelcomeEmily Akhtarzandi, Managing Director, AtlanticLIVE
    Chester “Chip” Davis, Jr.*, President and CEO, Association for Accessible Medicines
  • 8:30 a.m.The Role of CongressRepresentative Peter Welch (D-VT)
    With Steve Clemons, Washington Editor at Large, The Atlantic
  • 8:50 a.m.The Patent LandscapeBruce Artim, Senior Director, Federal Government Affairs, Eli Lilly and Company
    Courtenay Brinckerhoff, Partner, Foley & Lardner LLP
    Phil Nickson, Associate General Counsel, Intellectual Property, Momenta Pharmaceuticals
    With Olga Khazan, Staff Writer, The Atlantic
  • 9:20 a.m.Closing ThoughtsEmily Akhtarzandi, AtlanticLIVE

Underwriter

Also in This Series

Upcoming Events

  • Economy/Business

    The Renewal Summit: Houston

    How can Houston's community leaders bring opportunity to all residents of the region?

  • Politics

    What Do the Midterms Mean?
    With The Atlantic's Politics Team

    The midterm elections could define one of the most pivotal periods in America’s recent history. One week after the country votes, The Atlantic’s top political reporters and editor-in-chief Jeffrey Goldberg take stock of the results and analyze what they mean for the president, policy, and politics leading up to the 2020 presidential campaign.


    Tickets: $15 advance/$18 day of

  • Health Care

    People v. Cancer

    What will it take for humankind to conquer cancer?